Last reviewed · How we verify

NCT04859816: FAT-BAR

Fat Absorption and Metabolism After Roux-en-Y Gastric Bypass

Completed NA Last updated 23 August 2022
What this trial tests

NA trial testing Metabolic test in Bariatric Surgery in 24 participants. Completed in 1 May 2022.

Timeline
1 April 2021
Primary endpoint
1 May 2022
1 May 2022

Quick facts

Lead sponsorHvidovre University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationnon randomized
Designparallel
Maskingnone
Primary purposebasic science
Enrollment24
Start date1 April 2021
Primary completion1 May 2022
Estimated completion1 May 2022
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Hvidovre University Hospital

Who can join

Adults 18 to 75, any sex, with Bariatric Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Using intravenous and oral administration of stable isotope tracers, we will investigate the importance of altered fat absorption and altered whole body fat metabolism for the reduced postprandial systemic TAG concentrations in non-diabetic patients in weight stable phase after RYGB.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bariatric Surgery

Currently open trials in the same condition.

Other Hvidovre University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04859816.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing